Financhill
Back

Fortune Brands Innovations Vs. Bright Minds Biosciences Industry Stock Comparison

Sell
21

FBIN
Fortune Brands Innovations

Last Price:
$68.18
Seasonality Move:
2.16%
Sell
45

DRUG
Bright Minds Biosciences

Last Price:
$39.35
Seasonality Move:
-32.13%
Sell
21
Fortune Brands Innovations (FBIN) is a Sell

Is Fortune Brands Innovations a Buy, Sell or Hold?

  • The current Fortune Brands Innovations [FBIN] share price is $68.23. The Score for FBIN is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • FBIN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $39.85. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FBIN Stock Price Chart

What is Fortune Brands Innovations's stock price today?

  • The Fortune Brands Innovations share price today is $68.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FBIN is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $39.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.

FBIN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.82 Sell
Relative Strength Index (14 RSI): 28.67 Sell
Chaikin Money Flow: 600054 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (69.39 - 78.29) Sell
Bollinger Bands (100): (74.09 - 86.37) Sell

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 51.96 Buy
Chaikin Money Flow: 6916 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.23 - 42.31) Buy
Bollinger Bands (100): (3.23 - 44.21) Buy

FBIN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 68.88 Sell
20-day SMA: 72.68 Sell
50-day SMA: 77.06 Sell
200-day SMA: 76.49 Sell
8-day EMA: 69.05 Sell
20-day EMA: 71.73 Sell
50-day EMA: 75.7 Sell
200-day EMA: 76.53 Sell

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.78 Buy
20-day SMA: 38.81 Buy
50-day SMA: 41.79 Sell
200-day SMA: 12.42 Buy
8-day EMA: 39 Buy
20-day EMA: 39.09 Buy
50-day EMA: 36.04 Buy
200-day EMA: 18.43 Buy

Fortune Brands Innovations Earnings Growth & FBIN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and an increase next year of $0.58 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Fortune Brands Innovations Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):